THERAPYX, INC.
Therapy and Prophylaxis for Genital Tract Infection
Therapy and Prophylaxis for Genital Tract Infection is a funding opportunity from THERAPYX, INC., up to 1000000, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
ABSTRACT GneX12 is a patented therapeutic vaccine in development specifically for women with Neisseria gonorrhoeae (gonorrhea) infection. It is a novel formulation of recombinant human interleukin-12 (IL-12) encapsulated in biodegradable sustained release micro-particles. It is meant to be given in conjunction with…